Absci Corp (ABSI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Sean McClain
Employees:
169
18105 SE MILL PLAIN BLVD, VANCOUVER, WA 98683
(360) 949-1041

Our mission is to change the world, one protein at a time. We founded Absci with the goal of creating better medicines and helping them reach patients sooner. We recognized the extraordinary medical and economic potential of protein-based drugs (biologics), but also the significant challenges the biopharmaceutical industry faces to both discover novel biologics and generate cell lines to manufacture them at commercial scale.

Data derived from most recent annual or quarterly report
Market Cap 319.138 Million Shares Outstanding92.773 Million Avg 30-day Volume 499.446 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.39
Price to Revenue85.1984 Debt to Equity0.0185 EBITDA-99.773 Million
Price to Book Value1.1128 Operating Margin-1573.3584 Enterprise Value151.092 Million
Current Ratio8.065 EPS Growth0.348 Quick Ratio7.502
1 Yr BETA 2.2074 52-week High/Low 31.53 / 3.32 Profit Margin-2111.2505
Operating Cash Flow Growth-452.3974 Altman Z-Score3.3014 Free Cash Flow to Firm -156.867 Million
Earnings Report2022-08-15
View SEC Filings from ABSI instead.

View recent insider trading info

Funds Holding ABSI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABSI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BUSCH ANDREAS

  • Director
0 2022-03-17 2

SCHIFFMAN GREGORY T CHIEF FINANCIAL OFFICER

  • Officer
190,000 2022-02-21 2

WEINSTOCK MATTHEW CHIEF TECHNOLOGY OFFICER

  • Officer
215,000 2022-02-21 2

BEDRICK TODD VP, CCPAO

  • Officer
100,000 2022-02-21 4

KORMAN SARAH GENERAL COUNSEL

  • Officer
160,000 2022-02-21 5

MCCLAIN SEAN PRESIDENT AND CHIEF EXECUTIVE

  • Officer
  • Director
635,850 2022-02-21 4

SIROSH JOSEPH

  • Director
45,180 2022-01-07 3

PHOENIX VENTURE PARTNERS II LP

PHOENIX GENERAL PARTNER II LLC

  • 10% Owner
14,492,813 2021-08-13 3

MCGINNIS KAREN K

  • Director
15,000 2021-07-26 2

REDMILE GROUP, LLC

GREEN JEREMY

  • Director
8,031,094 2021-07-26 2

CASDIN PARTNERS MASTER FUND, L.P.

CASDIN CAPITAL, LLC

CASDIN PARTNERS GP, LLC

CASDIN PRIVATE GROWTH EQUITY FUND, L.P.

CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC

  • Director
7,718,593 2021-07-26 2

CASDIN ELI

  • Director
7,718,593 2021-07-26 2

PIHL ANDREAS CHIEF OPERATING OFFICER

  • Officer
607,937 2021-07-26 2

JONASSON ZACHARIAH

  • Director
9,000 2021-07-26 2

MAGOVCEVIC-LIEBISCH IVANA

  • Director
179,328 2021-07-21 1

REDMILE GROUP, LLC

REDMILE BIOPHARMA INVESTMENTS II, L.P.

GREEN JEREMY

  • Director
  • 10% Owner
0 2021-07-21 2

NAGPAL AMRIT

  • Director
0 2021-07-21 1

GOEL NIKHIL CHIEF BUSINESS OFFICER

  • Officer
0 2021-07-21 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ABSCI CORP ABSI 2022-05-19 12:45:03 UTC -2.2886 3.1086 150000
ABSCI CORP ABSI 2022-05-18 22:15:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 21:45:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 21:15:04 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 20:45:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 20:15:05 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 19:45:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 19:15:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 18:45:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 18:15:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 17:45:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 17:15:03 UTC -2.2886 3.1086 650000
ABSCI CORP ABSI 2022-05-18 16:45:03 UTC -2.288 3.108 650000
ABSCI CORP ABSI 2022-05-18 16:15:03 UTC -2.288 3.108 650000
ABSCI CORP ABSI 2022-05-18 15:45:03 UTC -2.288 3.108 650000
ABSCI CORP ABSI 2022-05-18 15:15:03 UTC -2.288 3.108 600000
ABSCI CORP ABSI 2022-05-18 14:45:03 UTC -2.3702 3.1902 600000
ABSCI CORP ABSI 2022-05-18 14:15:04 UTC -2.3702 3.1902 650000
ABSCI CORP ABSI 2022-05-18 13:45:03 UTC -2.3702 3.1902 650000
ABSCI CORP ABSI 2022-05-18 13:15:03 UTC -2.3702 3.1902 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund ABSI -1282.0 shares, $-10512.4 2021-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ABSI -3400.0 shares, $-27880.0 2021-12-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund ABSI -5051.0 shares, $-33993.23 2022-01-31 N-PORT

Elevate your investments